Normal fatty acid concentrations in young children with phenylketonuria

Topics in Clinical Nutrition

Volumn 24, Issue 4, 2009, Pages 333-340

  LaVoie, Stacey M ^a   Harding, Cary O ^a   Gillingham, Melanie B ^a  

^a OREGON HEALTH AND SCIENCE UNIVERSITY   (United States)

Author keywords

Fatty acids; Lipids; Phenylketonuria; PKU

Indexed keywords

FATTY ACID; OMEGA 3 FATTY ACID; OMEGA 6 FATTY ACID; PHENYLALANINE; POLYUNSATURATED FATTY ACID; SATURATED FATTY ACID;

ARTICLE; BLOOD SAMPLING; CHILD; CLINICAL ARTICLE; COMPARATIVE STUDY; CONCENTRATION (PARAMETERS); CONTROL GROUP; CONTROLLED STUDY; DIET RESTRICTION; DIETARY INTAKE; ESSENTIAL FATTY ACID DEFICIENCY; FATTY ACID BLOOD LEVEL; HUMAN; PHENYLKETONURIA; PRESCHOOL CHILD; PRIORITY JOURNAL; SCHOOL CHILD;

EID: 73949137248     PISSN: 08835691     EISSN: None     Source Type: Journal    
DOI: 10.1097/TIN.0b013e3181c621fa     Document Type: Article

References (25)

1. Infante JP, Huszagh VA. Impaired arachidonic (20:4n-6) and docosahexaenoic (22:6n-3) acid synthesis by phenylalanine metabolites as etiological factors in the neuropathology of phenylketonuria. Mol Genet Metab. 2001;72(3):185-198.
2. Schulz B, Bremer HJ. Nutrient intake and food consumption of adolescents and young adults with phenylketonuria. Acta Paediatr. 1995;84(4):743-748.
3. Agostoni C, Marangoni F, Riva E, Giovannini M, Galli C. Plasma arachidonic acid and serum thromboxane B2 concentrations in phenylketonuric children negatively correlate with dietary compliance. Prostaglandins Leukot Essent Fatty Acids. 1997; 56(3):219-222.
4. Agostoni C, Scaglioni S, Bonvissuto M, Bruzzese MG, Giovannini M, Riva E. Biochemical effects of supplemented long-chain polyunsaturated fatty acids in hyperphenylalaninemia. Prostaglandins Leukot Essent Fatty Acids. 2001;64(2):111-115. (Pubitemid 32234857)
5. Beblo S, Reinhardt H, Demmelmair H, Muntau AC, Koletzko B. Effect of fish oil supplementation on fatty acid status, coordination, and fine motor skills in children with phenylketonuria. J Pediatr. 2007;150(5): 479-484.
6. Galli C, Agostoni C, Mosconi C, Riva E, Salari PC, Giovannini M. Reduced plasma C-20 and C-22 polyunsaturated fatty acids in children with phenylketonuria during dietary intervention. J Pediatr. 1991;119(4):562-567.
7. Giovannini M, Agostoni C, Biasucci G, et al. Fatty acid metabolism in phenylketonuria. Eur J Pediatr. 1996; 155(suppl 1):S132-S135.
8. Pöge AP, Bäumann K, Muller E, Leichsenring H, Schmidt H, Bremer HJ. Long-chain polyunsaturated fatty acids in plasma and erythrocyte membrane lipids of children with phenylketonuria after controlled linoleic acid intake. J Inherit Metab Dis. 1998; 21(4):373-381.
9. Acosta PB, Yannicelli S, Singh R, et al. Intake and blood levels of fatty acids in treated patients with phenylketonuria. J Pediatr Gastroenterol Nutr. 2001;33(3):253-259.
10. Agostoni C, Massetto N, Biasucci G, et al. Effects of long-chain polyunsaturated fatty acid supplementation on fatty acid status and visual function in treated children with hyperphenylalaninemia. J Pediatr. 2000;137(4):504-509.
11. Dyer CA. Pathophysiology of phenylketonuria. MRDD Res Rev. 1999;5(2):104-112.
12. Rose HJ, White F, MacDonald A, Rutherford PJ, Favre E. Fat intakes of children with PKU on low phenylalanine diets. J Hum Nutr Dietet. 2005;18(5):395-400.
13. Moseley K, Koch R, Moser AB. Lipid status and long-chain polyunsaturated fatty acid concentrations in adults and adolescents with phenylketonuria on phenylalanine-restricted diet. J Inherit Metab Dis. 2002;25(1):56-64.
14. Arab L. Biomarkers of fat and fatty acid intake. J Nutr. 2003;133(suppl 3):925S-932S.
15. Skeaff CM, Hodson L, McKanzie JE. Dietary-induced changes in fatty acid composition of human plasma, platelet, and erythrocyte lipids follow a similar time course. J Nutr. 2006;136(3):565-569.
16. Gillingham MB, Connor WE, Matern D, et al. Optimal dietary therapy of long-chain 3-hydroxyacyl-CoA dehydrogenase deficiency. Mol Genet Metab. 2003;79(2):114-123.
17. Goyens PLL, Spilker ME, Zock PL, Katan MB, Mensick RP. Conversion of α-linolenic acid in humans in influenced by the absolute amounts of α-linolenic acid and linoleic acid in the diet and not by their ratio. Am J Clin Nutr. 2006;84(1):44-53.
18. Lagerstedt SA, Hinrichs DR, Batt SM, Magera MJ, Rinaldo P, McConnell JP. Quantitative determination of plasma C8-C26 total fatty acids for the biochemical diagnosis of nutritional and metabolic disorders. Mol Genet Metab. 2001;73(1):38-45.
19. Connor WE, Neuringer M, Reisbick S. Essential fatty acids: The importance of n-3 fatty acids in the retina and brain. Nutr Rev. 1992;50(4, Pt 2):21-29.
20. Innis S. The role of dietary n-3 and n-6 fatty acids in the developing brain. Dev Neurosci. 2000;22(5/6): 474-480.
21. MacDonald A, Chakrapani A, Hendriksz C, et al. Protein substitute dosage in PKU: How much do young patients need? Arch Dis Child. 2006;91(7):588-593.
22. McBurnie M, Kronmal RA, Schuett VW, Koch R, Azeng CG. Physical growth of children treated for phenylketonuria. Ann Hum Biol. 1991;18(4):357-368.
23. Schulpi KH, Scarpalezou A. Triglycerides, cholesterol, HDL, LDL, and VLDL cholesterol in serum of phenylketonuric children under dietary control. Clin Pediatr. 1989;28(10):466-469.
24. Acosta PB, Alfin-Slater RB, Koch R. Serum lipids in children with phenylketonuria (PKU). J Am Diet Assoc. 1972;63(12):631-635.
25. Galluzzo CR, Ortisi MT, Castelli L, Agostoni C, Longhi R. Plasma lipid concentrations in 42 treated phenylketonuric children. J Inherit Metab Dis. 1985;8(suppl 2):129.